- Home
- SMTK vs PRPH Comparison
SMTK vs PRPH Comparison
Compare SMTK & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTK
- PRPH
- Stock Information
- Founded
- SMTK 2009
- PRPH 1989
- Country
- SMTK United Kingdom
- PRPH United States
- Employees
- SMTK N/A
- PRPH N/A
- Industry
- SMTK
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- SMTK
- PRPH Health Care
- Exchange
- SMTK NYSE
- PRPH Nasdaq
- Market Cap
- SMTK 13.3M
- PRPH 10.7M
- IPO Year
- SMTK N/A
- PRPH 1997
- Fundamental
- Price
- SMTK $2.75
- PRPH $0.35
- Analyst Decision
- SMTK
- PRPH
- Analyst Count
- SMTK 0
- PRPH 0
- Target Price
- SMTK N/A
- PRPH N/A
- AVG Volume (30 Days)
- SMTK 103.6K
- PRPH 1.7M
- Earning Date
- SMTK 05-12-2025
- PRPH 03-31-2025
- Dividend Yield
- SMTK N/A
- PRPH N/A
- EPS Growth
- SMTK N/A
- PRPH N/A
- EPS
- SMTK N/A
- PRPH N/A
- Revenue
- SMTK $82,000.00
- PRPH $6,770,000.00
- Revenue This Year
- SMTK N/A
- PRPH N/A
- Revenue Next Year
- SMTK N/A
- PRPH $64.06
- P/E Ratio
- SMTK N/A
- PRPH N/A
- Revenue Growth
- SMTK 203.70
- PRPH N/A
- 52 Week Low
- SMTK $2.01
- PRPH $0.22
- 52 Week High
- SMTK $13.00
- PRPH $7.48
- Technical
- Relative Strength Index (RSI)
- SMTK N/A
- PRPH 44.34
- Support Level
- SMTK N/A
- PRPH $0.35
- Resistance Level
- SMTK N/A
- PRPH $0.52
- Average True Range (ATR)
- SMTK 0.00
- PRPH 0.08
- MACD
- SMTK 0.00
- PRPH -0.00
- Stochastic Oscillator
- SMTK 0.00
- PRPH 23.00
About SMTK SMARTKEM INC
SmartKem Inc focuses on the design, development, industrialization, and technology transfer of low-temperature, solution-deposited organic semiconductors for transistor backplanes. The company's semiconductor platform can be used in a number of applications including mini-LED displays, AMOLED displays, fingerprint sensors, and logic circuits. The company derives revenue from the sale of TRUFLEX inks and demonstration products.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.